CASI Pharmaceuticals, Inc.
CASI
|
$2.24
4.7K
|
Health Technology
(0.0% 1d) (-24.0% 1m) (-24.3% 1y) (0.0% 2d) (0.0% 3d) (-10.0% 7d) (185.28% volume)
Earnings Calendar: 2023-11-14
Market Cap: $ 30,019,080
http://www.casipharmaceuticals.com
Sec Filling | Patents | 125 employees
(US) CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
acquisitions cancer china
add to watch list Paper trade email alert is off
Press-releases
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
Published: 2024-04-08 (Crawled : 21:00) - prnewswire.com
CASI | $2.24 4.7K
|
Health Technology
|
| O: -1.29%
H: 3.91%
C: 1.95%
pharmaceuticals
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
Published: 2024-03-28 (Crawled : 11:00) - prnewswire.com
CASI | $2.24 4.7K
|
Health Technology
|
| O: -1.67%
H: 26.1%
C: 22.37%
business pharmaceuticals financial results
CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China
Published: 2024-03-05 (Crawled : 12:00) - prnewswire.com
CASI | $2.24 4.7K
|
Health Technology
|
| O: 21.93%
H: 10.65%
C: -8.71%
bi-1206 report positive treatment pharmaceuticals china
CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA
Published: 2024-02-16 (Crawled : 12:00) - prnewswire.com
CASI | $2.24 4.7K
|
Health Technology
|
| O: -2.85%
H: 3.66%
C: 0.0%
folotyn first pharmaceuticals china
CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA
Published: 2023-11-08 (Crawled : 13:00) - biospace.com/
CASI | $2.24 4.7K
|
Health Technology
|
| O: 0.0%
H: 5.07%
C: -0.97%
cnct19 approval pharmaceuticals china market
CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
Published: 2023-08-11 (Crawled : 11:00) - prnewswire.com
CASI | $2.24 4.7K
|
Health Technology
|
| O: 2.22%
H: 1.3%
C: 1.3%
business pharmaceuticals financial
Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals
Published: 2023-08-01 (Crawled : 11:00) - prnewswire.com
CASI | $2.24 4.7K
|
Health Technology
|
| O: 2.9%
H: 1.61%
C: 0.0%
folotyn transfer license corporation international biopharma pharmaceuticals medical agreement china
CASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339
Published: 2023-07-20 (Crawled : 21:00) - biospace.com/
CASI | $2.24 4.7K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.34%
cb-5339 pharmaceuticals global
Cleave Therapeutics Announces Acquisition of Clinical and Preclinical Assets
Published: 2023-07-20 (Crawled : 13:00) - biospace.com/
CASI | $2.24 4.7K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.34%
acquisition preclinical therapeutics
CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
Published: 2023-05-17 (Crawled : 13:00) - biospace.com/
CASI | $2.24 4.7K
|
Health Technology
|
| O: -3.87%
H: 9.16%
C: -3.75%
pharmaceuticals financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Last 48 Hours Insiders Buying
QCRH | $55.405 1.33% 13K
|
Finance
|
18:01
RVP P 15363 | $1.04 14K
|
Health Technology
|
18:00
VUZI | $1.33 9.02% 540K
|
Electronic Technology
|
18:00
TPL P 3 | $592.6 1.31% 22K
|
Miscellaneous
|
15:00
RELL | $10.24 3.85% 36K
|
Electronic Technology
|
13:30
IZEA | $2.53 20K
|
Technology Services
|
00:00
RKT P 383 | $11.735 3.12% 640K
|
Finance
|
22:30
CTRN P 18090 | $22.39 0.09% 33K
|
Retail Trade
|
22:00
BRN P 10650 | $2.8 0.36% 44K
|
Energy Minerals
|
21:00
NEOG P 10000 | $11.85 -2.39% 1.7M
|
Health Technology
|
16:30
RMCF | $3.53 1.7K
|
Consumer Non-Durables
|
20:10